2019
DOI: 10.1007/s00705-019-04352-4
|View full text |Cite
|
Sign up to set email alerts
|

MTTP polymorphisms and hepatic steatosis in individuals chronically infected with hepatitis C virus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
1
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 21 publications
1
1
0
2
Order By: Relevance
“…This study began with a comprehensive screening based on strict inclusion and exclusion criteria, and subsequently included novel publications from recent years. The result found the dominant model (GT + TT) is positively correlated with an increased risk of liver steatosis associated with hepatitis C. Notably, the risk of liver steatosis increased significantly when the HCV genotype 3 was combined with a dominant model of MTTP mutations, which is consistent with the findings by Tao Cai [ 25 , 26 ]. In contrast, no correlation to hepatic steatosis susceptibility was observed in other mutation models.…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…This study began with a comprehensive screening based on strict inclusion and exclusion criteria, and subsequently included novel publications from recent years. The result found the dominant model (GT + TT) is positively correlated with an increased risk of liver steatosis associated with hepatitis C. Notably, the risk of liver steatosis increased significantly when the HCV genotype 3 was combined with a dominant model of MTTP mutations, which is consistent with the findings by Tao Cai [ 25 , 26 ]. In contrast, no correlation to hepatic steatosis susceptibility was observed in other mutation models.…”
Section: Discussionsupporting
confidence: 88%
“…In the HCV genotype 3, the core protein has the strongest effect on lipid accumulation by inhibiting the expression of the MTTP protein and preventing the secretion of lipoproteins [ 7 , 34 ]. Accordingly, patients with the HCV genotype 3 have an increased risk of liver steatosis when carrying the dominant MTTP genotype [ 26 ]. Since the expression levels of the MTTP gene dynamically changes during the early and late stages of HCV infection, assessing the risk of liver steatosis depends on monitoring changes in MTTP genotype expression during early HCV infection.…”
Section: Discussionmentioning
confidence: 99%
“…propose that upregulation of MTTP benefits viral replication early in infection, while chronic inhibition of MTP contributes to viral persistence. Other MTTP variants that have been reported to contribute to hepatic steatosis in genotype 3 infection include −164T/C (rs1800804) and −400A/T (rs1800803) 213 . Hepatic SREBP is also upregulated in chronic HCV infection, 208 corresponding to increases in de novo lipogenesis that are essential for HCV replication and release, according to Narayanan et al 214 …”
Section: Clds Associated With Hepatic Steatosis (Slds)mentioning
confidence: 99%
“…Empregou-se a equação recomendada para esse tipo de estudo: n=π (1-π) /e2, onde n = tamanho da amostra (mínimo requerido), π = proporção de interesse, e = erro padrão (Kirkwood;Sterne, 2006). Nota: os SNPs -164T/C, -400A/T, H297Q e -493G⁄T foram previamente genotipados nesse grupo (Magri et al, 2017;Prata et al, 2019a, Prata, 2019b. No presente estudo esses dados foram submetidos a novas análises estatísticas e genéticas.…”
Section: Tamanho De Amostra Grupo 1 -Portadores Crônicos Do Hcvunclassified
“…Além disso, foi observado uma associação estatisticamente significante entre os alelos mutados para os polimorfismos -164T/C e -400A/T juntamente com a infecção pelo genótipo 3 do HCV e a ocorrência de esteatose nesses pacientes. Desse modo, sugere-se que a combinação de fatores hospedeiros e fatores virais podem potencialmente ser utilizados para prever a esteatose hepática(Prata et al, 2019a). Na Tabela 3 estão apresentados alguns estudos que avaliaram a influência de polimorfismos no gene MTTP em pacientes com hepatite C. não está clara a relação entre os SNPs no gene MTTP e a susceptibilidade para resistência à insulina e esteatose hepática em portadores crônicos do HCV.…”
unclassified